GLENMARK PHARMACEUTICALS
Back to Cashflow Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹2.09 Cr | ₹4,561 Cr | ₹-528 Cr | ₹-333 Cr | ₹-675 Cr |
What is the latest Cash Flow from Investing Activities ratio of GLENMARK PHARMACEUTICALS ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹2.09 Cr |
| Mar2024 | ₹4,561 Cr |
| Mar2023 | ₹-528 Cr |
| Mar2022 | ₹-333 Cr |
| Mar2021 | ₹-675 Cr |
How is Cash Flow from Investing Activities of GLENMARK PHARMACEUTICALS Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.09 Cr | -99.95 | |
| Mar2024 | ₹4,561 Cr | Positive | |
| Mar2023 | ₹-528 Cr | Negative | |
| Mar2022 | ₹-333 Cr | Negative | |
| Mar2021 | ₹-675 Cr | - | |
Compare Cash Flow from Investing Activities of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹61,657.9 Cr | -7.1% | -9.2% | 59% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹429,469.0 Cr | -2.8% | -1% | 6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,305.0 Cr | -3.3% | 0.4% | -2.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,014.0 Cr | -3.1% | 2.9% | 36.9% | Stock Analytics | |
| CIPLA | ₹111,388.0 Cr | -2.7% | 5.3% | -6.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,381.0 Cr | -4.1% | -3.7% | 3.7% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -7.1% |
-9.2% |
59% |
| SENSEX | -2.4% |
-3.7% |
-9.2% |
You may also like the below Video Courses